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O B J E C T I V E S We sought to evaluate whether echocardiographic diastolic function indices corre-
late with myocardial iron and systolic function in patients with transfusion-dependent thalassemia (TDT)
who are at risk for cardiomyopathy.
B A C KG ROUND In thalassemia syndromes, there is an important clinical need to risk stratify
patients for the development of iron-overload cardiomyopathy so that chelation therapy can be
adjusted and cardiac morbidity averted. This purpose may be served by measuring the magnetic
resonance imaging (MRI)-derived parameter T2*, which varies inversely with tissue iron concentration
but has limited availability. As diastolic dysfunction may precede systolic dysfunction, we sought to
directly compare more readily available echocardiographic indices of diastolic function to myocardial
T2* and ejection fraction (EF).
METHOD S We identiﬁed 47 paired echocardiography and MRI examinations in 24 patients with
TDT. Echocardiographic measurements of transmitral ﬂow velocities (E, A), tissue Doppler velocities (E=),
and left ventricular volume and EF were compared with MRI measurements of myocardial T2*,
ventricular volume, and EF.
R E S U L T S All patients had a restrictive ﬁlling pattern (E/A1.5 and deceleration time140 ms) and
normal relaxation. There was no signiﬁcant correlation between E/E’ or the Tei index versus EF. Although
E/A and E= had statistically signiﬁcant correlations with EF, the relationships were weak with all
correlation coefﬁcients 0.52. The parameters E/A, E=, E/E=, and the Tei index did not signiﬁcantly
correlate with myocardial iron concentration as assessed by MRI T2*. Increased myocardial iron as
measured by T2* was strongly associated with lower left ventricular EF, with a T2* 9 ms having a
sensitivity of 100% and speciﬁcity of 89% for MRI EF 50%.
CONC L U S I O N S In patients with TDT, echocardiographic diastolic function parameters correlated
poorly with EF and myocardial T2* and were thus not well-suited for risk stratiﬁcation. Myocardial T2*
had a strong relationship with EF and appears to be a promising approach for predicting the
development of heart failure and for iron chelator dose adjustment. (J Am Coll Cardiol Img 2008;1:
572–8) © 2008 by the American College of Cardiology Foundation
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573lthough treatment with chronic blood trans-
fusions and chelation therapy has improved
survival in patients with thalassemia major,
mortality remains high with heart failure
aused by transfusion iron overload accounting for
p to 71% of all deaths from this disease (1–5).
eterioration in left ventricular (LV) systolic func-
ion is often rapid and unpredictable in this condi-
ion, and once heart failure has developed, the
rognosis is poor (6). There is thus an important
linical need to reliably risk stratify patients for the
evelopment of heart failure and arrhythmia so that
helation therapy can be intensified and cardiac
orbidity averted.
See page 579
One promising approach to this challenge has
een the development of magnetic resonance im-
ging (MRI) techniques to noninvasively quantify
yocardial iron content to detect pre-clinical evi-
ence of potentially toxic levels within the myocar-
ium. The MRI-derived relaxation time parameter,
2*, varies inversely with iron concentration be-
ause iron interferes with local magnetic field ho-
ogeneity. Elevated myocardial iron levels by T2*
ave been shown to be associated with depressed
V ejection fraction (EF) (7) and improve in
oncert with LV function during recovery (3,8,9).
evertheless, the clinical impact of T2* assessment
ill likely be limited by the availability and cost of
RI examinations in much of the developing world
here thalassemia is quite prevalent.
Left ventricular diastolic function might be a more
ensitive marker of the adverse effects of excess myo-
ardial iron overload than systolic function, as has
een shown in ischemic heart disease. Diastolic func-
ion can be assessed by echocardiographic techniques,
hich are more readily available and less expensive
han MRI. We therefore sought to directly compare
chocardiographic indices of diastolic function to
yocardial T2* and EF in a cohort of transfusion-
ependent thalassemia (TDT) patients.
E T H O D S
tudy population. A retrospective database review
dentified all patients with TDT who underwent
oth echocardiography and MRI T2* assessment at
hildren’s Hospital Boston. All patients had been
egularly transfused since early childhood to main-
ain hemoglobin levels above 10 g/dl. All patients
ere prescribed chelation therapy with deferox- wmine typically beginning before the age of 7 years.
he conventional chelation treatment was subcuta-
eous infusion of deferoxamine in a daily dose 30 to
0 mg/kg, 5 to 6 times per week. Chelation therapy
as monitored by frequent estimation of ferritin. A
erum ferritin level below 2,000 ng/ml was consid-
red to be an indicator of successful treatment with
eferoxamine. None of the patients were in heart
ailure at the time of imaging assessment, although
ome patients had a prior history of heart failure.
ermission for a database and medical record review
as granted by the Children’s Hospital Boston
ommittee on Clinical Investigation.
RI techniques and data analysis. Magnetic reso-
ance imaging examinations were routinely per-
ormed within 10 days of transfusion. Iron in the
yocardium was quantified by measuring T2*
1/R2*), a MR relaxation parameter that has been
hown to vary inversely with tissue iron concentra-
ion (7,10,11). This technique has high reproduc-
bility and inter-MRI scanner agreement
7,12–14). Magnetic resonance imaging
easurements were performed using a
.5-T clinical MRI scanner (initially a
eneral Electric TwinSpeed, General
lectric Medical Systems, Waukesha,
isconsin; more recently a Philips Achieva,
hilips Medical System, Best, the Neth-
rlands) and a torso surface coil. Myocar-
ial T2* was assessed from a single mid-
apillary ventricular short-axis slice using
cardiac-gated, segmented, multiecho
radient echo sequence obtained in a sin-
le breath-hold, similar to the technique described
y Westwood et al. (13). Eight echoes with a
inimum echo time (TE) of 2.0 ms, an echo
pacing of 2.2 ms, and a repetition time of 19.1 ms
ere obtained.
The T2* values were calculated using custom-
ritten software developed in MATLAB (The
athWorks, Natick, Massachusetts) by Dr. John
. Wood and adapted by Dr. Yansong Zhao. A
egion of interest was manually defined encompass-
ng the ventricular septum. The signal decay of each
ixel within the region of interest was fit to a
onoexponential decay with a constant offset [S 
0 exp(TE  R2*)  C]. The mean value was
sed as the R2* for that region and its reciprocal was
aken to yield T2*.
Measurements of ventricular EF were made us-
ng standard MRI techniques. A stack of 12 short-
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574reath-hold steady-state free precession cine se-
uence. Ventricular volumes were measured off-line
sing commercially available software (MASS, Lei-
en, the Netherlands) with manual identification of
yocardial borders and a summation of disks algo-
ithm. Systolic LV dysfunction was defined as mild
f the EF was 41% to 55%, moderate if 31% to 40%,
nd severe if 30%.
chocardiography. Complete 2-dimensional,
oppler, and tissue-Doppler echocardiography was
erformed, using Sonos 5500 or 7500 Philips ultra-
ound systems (Philips Medical Systems, Andover,
assachusetts). Left ventricular end-diastolic and
nd-systolic volumes were calculated using a mod-
fied Simpson’s algorithm based on long- and short-
xis images, and the EF was calculated. Systolic LV
ysfunction was defined as mild if the EF was 41%
o 55%, moderate if 31% to 40%, and severe if
30%. Left ventricular diastolic function was as-
essed using pulsed-Doppler samples of mitral in-
ow and pulsed-tissue Doppler at the level of the
ateral wall of the mitral annulus. Standard diastolic
ndices were recorded, including early (E) and late
A) transmitral peak flow velocities, early decelera-
ion time (DT), and LV isovolumic relaxation time
IVRT). Deceleration time was measured as the
ime between the peak E velocity and the point
here the velocity returns to 0. The peak velocities
cm/s) of the myocardial systolic wave and of the
arly (E=) and late (A=) diastolic tissue Doppler
ignals were measured and the E/E= ratio was
alculated. The pattern of LV filling was classified
s restrictive if E/A 1.5 and DT 140 ms, as
mpaired relaxation if E/A 0.75, and as pseudo-
ormal if (0.75  E/A 1.5 and DT 140 ms and
/E= 10) (15). The IVRT, LV ejection time
ET), and duration of mitral closure (DMC) were
easured from pulsed-Doppler samples as the time
rom the end of antegrade flow across the LV
utflow tract to the onset of the diastolic mitral
nflow signal, the duration of antegrade flow across
he LV outflow tract, and the time from the
ermination to the onset of the diastolic mitral
nflow signal, respectively. Isovolumetric contrac-
ion time (IVCT) was calculated as DMC  (ET
IVRT). The Tei index was calculated as (IVCT
IVRT)/(ET) (16).
tatistical analysis. Correlations between the myo-
ardial T2* and the indices of LV systolic and
iastolic function were calculated using least-square
inear regression. A p value of 0.05 was consid-
red statistically significant. The sensitivity and
pecificity of T2* for ventricular dysfunction on MRI or echocardiography were evaluated using
eceiver operating characteristic curve analysis.
E S U L T S
atients. A total of 24 patients (15 male, mean age
8  10 years, age range 11 to 48 years) were
dentified with TDT who underwent both echocar-
iography and MRI T2* assessment. Mean pre-
ransfusion hemoglobin level was 9.1  1.9 g/dl
range 6.1 to 12.1), and the average serum ferritin
evel was 2,380  2,002 ng/ml (range 79 to 7,727
g/ml).
chocardiography ﬁndings. There were 80 echocar-
iograms available in this cohort. The mean LV
nd-diastolic volume, end-systolic volume, and EF
ere, respectively, 158 65 ml, 77 51 ml, and 53
12%. The mean E/A, E/E=, and E= were,
espectively, 2.4  0.69, 7.3  5.44, and 15  5
m/s. The mean Tei index was 0.56  0.15. All
atients had a restrictive filling pattern (E/A 1.5
nd DT 140 ms) and normal relaxation. The
chocardiographic EF had a significant negative
orrelation with E/A (r  0.27, p  0.05) and a
ignificant positive correlation with E= (r  0.38, p
0.01) but was not significantly correlated with
/E= (r  0.08, p  0.59) or the Tei index (r 
.22, p 0.23). No threshold effects were observed.
There were 47 paired echocardiograms and MRI
xaminations in the 24 patients within 1 month of
ach other and the comparison between echocardi-
graphy and MRI was restricted to this subset. The
esults for this subset of echocardiographic exami-
ations were similar to the overall results with a
ean LV end-diastolic volume, end-systolic vol-
me, and EF of 156  57 ml, 72  44 ml, and 55
12%, respectively. Systolic function as measured
y echocardiographic EF was classified as normal in
2 cases, mild dysfunction in 9 cases, moderate
ysfunction in 4 cases, and severe dysfunction in 2
ases.
RI ﬁndings. There were 47 MRI examinations in
he 24 patients that were performed within 1 month
f an echocardiogram. The mean LV end-diastolic
olume, end-systolic volume, and EF derived from
RI were 172  62 ml, 79  46 ml, and 56 
1%, respectively. Systolic function as measured by
F was classified as normal in 33 cases, mild
ysfunction in 7 cases, moderate dysfunction in 6
ases, and severe dysfunction in 1 case.
Myocardial T2* was obtained in all but 2 exam-






























































J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 , N O . 5 , 2 0 0 8
S E P T E M B E R 2 0 0 8 : 5 7 2 – 8
Leonardi et al.
Iron and Ventricular Function in Thalassemia
575ith 7 of them having a T2* 10 ms. There was a
ignificant correlation between 1/T2* and EF by
RI (r  0.58, p  0.001) and between 1/T2* and
F by echocardiography (r  0.62, p  0.001). As
hown in Figure 1, the relationships between T2*
nd EF were highly nonlinear with a threshold
ffect clearly evident. Receiver operating character-
stic analysis was used to explore the sensitivity and
pecificity of threshold values of T2* for ventricular
ysfunction, and the results of this analysis are
resented in Figure 2. Using a T2* threshold value
f 9 ms, sensitivity  1 and specificity  0.89 for a
RI EF 50%, sensitivity  0.77 and specificity
0.87 for a MRI EF 55%, sensitivity  1 and
pecificity  0.83 for echocardiographic EF 50%,
nd sensitivity  0.71 and specificity  0.84 for an
chocardiographic EF 55%. There was a signifi-
ant correlation between myocardial 1/T2* and
erum ferritin (r  0.45, p  0.01). The correlation
etween myocardial 1/T2* and age was not signif-
cant (r  0.13, p  0.41).
omparison between MRI and echocardiography.
agnetic resonance imaging EF had a significant
egative correlation with E/A (r 0.52, p 0.002)
nd a significant positive correlation with E= (r 
.39, p  0.03), but was not significantly corre-
ated with E/E= (r  0.11, p  0.54) or the Tei
ndex (r  0.42, p  0.06). In contrast, myocardial
/T2* was not significantly correlated with E/A
r  0.15, p  0.42), E/E= (r  0.27, p  0.15),
= (r  0.21, p  0.26), or the Tei index (r  0.06,
 0.78).
Left ventricular size and function measurements
y MRI and echocardiography were compared in
he 47 instances with paired studies. End-diastolic
nd end-systolic volumes by the two techniques had
airly good agreement (mean difference  standard
eviation 14.6 22.1 ml) with MRI volumes being
n average 14% higher than those obtained by
chocardiography. Ejection fraction was highly cor-
elate with no significant difference between the 2
odalities (mean difference  standard deviation
.5  5.1%). Classification of severity of dysfunc-
ion (as defined in the Methods section) by echo-
ardiography and MRI agreed in 39 of 47 instances
nd was different by no more than 1 category in all
nstances.
I S C U S S I O N
his study compared echocardiographic indices of
iastolic function to myocardial T2* and EF in a
ohort of 24 TDT patients. We found that all satients had a restrictive filling pattern (E/A 1.5
nd DT 140 ms) and normal relaxation. There
as no significant correlation between E/E= or the
ei index versus LVEF (measured by either MRI or
chocardiography). Although E/A and E= had sta-
istically significant correlations with EF, the rela-
ionships were weak (all correlation coefficients
0.52). The parameters E/A, E=, E/E=, and the
ei index did not correlate with myocardial iron
oncentration (1/T2*). In contrast, we found that
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Figure 1. Relationship Between EF and Myocardial T2*
Among 24 subjects with transfusion-dependent thalassemia, there w
paired echocardiograms and magnetic resonance imaging (MRI) exa
tions performed within 1 month of each other. Left ventricular ejec
tion (EF) was measured with both echocardiography and MRI. Myoc
T2*, a parameter that varies inversely with tissue iron concentration
measured by MRI and T2* 20 ms indicates an elevated iron level.
ure shows the relationship between myocardial T2* and percent EF
sured by MRI (A) and by echocardiogram (B). Note that all patients
depressed EF (50%) by either modality have evidence of elevated
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5769 ms having a sensitivity of 100% and specificity
f 89% for a MRI EF 50%.
The principal goal of a cardiac surveillance pro-
ram in patients with TDT is to allow optimal
itration of iron chelator medications to prevent the
evelopment of cardiac dysfunction and arrhythmia
hile avoiding chelator-associated toxicities. Peri-
dic monitoring of systolic function is not adequate
or this task because of the rapid deterioration in
ystolic function that is commonly observed (inad-
quate sensitivity) (6). Left ventricular diastolic
ysfunction precedes the onset of systolic dysfunc-
ion in ischemic cardiomyopathy. Therefore, some
esearchers have proposed that LV diastolic func-
ion may be more sensitive as an early marker of
yocardial iron overload and thus serve as a guide
or adjusting chelator therapy. Several noninvasive
1 - Specificity







































erating Characteristic Curve Analysis
haracteristic curve analysis was used to explore the sensitivity and sp
hreshold value of 9 ms, sensitivity  1 and speciﬁcity  0.86 for a M
1 and speciﬁcity  0.83 for echocardiographic EF 50% (C), and se
rdial T2* had a strong relationship with EF and appears to be a prom
adjustment. Abbreviations as in Figure 1.echniques have been used in clinical practice to issess LV diastolic function in TDT, including
adionuclide ventriculography (17), Doppler echo-
ardiography of transmitral flow, and tissue-
oppler imaging (17–19). Although the presence
f abnormalities of diastolic function is often noted
n the absence of systolic dysfunction, as we also
ound in this study, the clinical significance of these
bnormalities remains unclear. The potential clini-
al utility of subclinical diastolic functional abnor-
alities is the identification of patients at high risk
or systolic dysfunction and clinical heart failure.
he ability of diastolic function indices to identify
DT patients who are at risk for heart failure has
ot been shown by others (17–19) and is not
upported by our data. We found that diastolic
unction indices were abnormal in this cohort,
egardless of systolic function. Although we did
1 - Specificity
0.2 0.4 0.6 0.8 1
1 - Specificity
0.2 0.4 0.6 0.8 1
city of threshold values of myocardial T2* for left ventricular dys-
F 50% (A), sensitivity  0.77 and speciﬁcity  0.85 for a MRI EF
ivity  0.71 and speciﬁcity  0.84 for an echocardiographic EF





































A receiver operating c eciﬁ
function. Using a T2* t RI E
55% (B), sensitivity  nsit
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577ween several of the echocardiographic indices of
iastolic function and LVEF, the correlations are
oo weak for this to be a clinically useful method
or adjusting chelator dose. An important poten-
ial confounder in this regard is the pre-load
ependence of these diastolic indices, because the
eriodic variation in blood volume associated with
evelopment of anemia and the regular administra-
ion of blood transfusions in TDT have a significant
ffect on pre-load. Although tissue-Doppler im-
ging has been shown to be less pre-load depen-
ent than mitral valve Doppler in assessing dia-
tolic function (20,21), this dependence is not
liminated.
Another approach to assessing the potential util-
ty of diastolic function parameters in TDT is to
ompare them with myocardial MRI T2* measure-
ents. Myocardial T2* has been shown to correlate
ell with biopsy-derived iron concentration in the
eart (10,22–24), and myocardial T2* values 20
s (indicating elevated iron) were found to be
ssociated with LV dysfunction (7,25) and improve
n concert with LV function during recovery
3,8,9). Our data are in agreement with these prior
tudies and showed a strong association between
2* values 9 ms and depressed LVEF. However,
e failed to identify a significant correlation be-
ween the diastolic function parameters E/A, E=,
nd E/E= and myocardial T2*, suggesting that these
re a poor reflection of myocardial iron concentra-
ion. There are only few other reports comparing
chocardiographic diastolic function indices with
yocardial T2*. Aessopos et al. (26) related a
ariety of parameters including E, A, and E/A but
ot tissue-Doppler indices to myocardial T2*. They
ound statistically significant correlations between
 and E/A versus T2* but these were not strong
r  0.5) and lacked discriminatory power to
dentify patients with myocardial iron overload yet
ormal systolic function. Vogel et al. (18) found
hat although abnormal tissue-Doppler measure-
ents were more common in thalassemia patients
ith myocardial iron overload, they were alsoJH, et al. Survival in medically treated spective study usingielding a specificity of only 65% to detect abnormal
ron loading. Westwood et al. (27) used MRI-
erived ventricular volume-time curves to measure
arly and atrial peak filling rates and found that
iastolic parameters were weakly correlated with
yocardial iron loading. These reports are in agree-
ent with our findings in that they identify that
bnormal diastolic function indices are frequently
resent in TDT patients but have insufficient spec-
ficity to identify patients who are at risk for
eveloping systolic dysfunction.
tudy limitations. The principal limitation of our
tudy is its relatively small sample size, which
iminishes its power to detect associations between
iastolic parameters and EF and myocardial T2*.
evertheless, there were a sufficient number of
atients and range of LV function to allow identi-
cation of a strong relationship between myocardial
2* and LV function. In addition, the application
f standard adult criteria for defining a restrictive
lling pattern to a patient group with chronic and
yclical volume overload may have limitations. The
linical implications of a restriction in this setting
ay not be the same as in patients with other causes
f cardiomyopathy.
O N C L U S I O N S
one of the echocardiographic diastolic function
arameters examined in this study were found to be
uitable for cardiac surveillance in TDT patients.
yocardial T2* measured by MRI, in contrast,
ad a strong relationship with LVEF and appears
o be a promising approach for cardiac risk
tratification and iron chelator dose adjustment in
atients with TDT. Longitudinal studies are
eeded to evaluate the utility of echocardio-
raphic and MRI parameters to predict cardiac
vents.
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